
    
      -  Patient treated at the first clinical contact

        -  18 sites (hospitals) in France

        -  Treatment during 48 weeks with principal objective at W24 (plasma HIV-RNA < 50
           copies/ml)

        -  Evaluation of antiretroviral treatment adherence using determination of Bictegravir,
           Emtricitabine and Tenofovir in hair sample
    
  